{"disease":{"id":"chronic-hepatitis-d","name":"chronic hepatitis d"},"drugs":{"marketed":[{"drug_id":"bulevirtide","indication_name":"Chronic infection caused by Hepatitis D virus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hepcludex","generic_name":"BULEVIRTIDE","company_name":"MYR GmbH","drug_phase":"marketed","molecular_target":"Sodium/bile acid cotransporter","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"bulevirtide","indication_name":"Chronic viral hepatitis B with hepatitis D","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hepcludex","generic_name":"BULEVIRTIDE","company_name":"MYR GmbH","drug_phase":"marketed","molecular_target":"Sodium/bile acid cotransporter","drug_class":"","quality_score":17,"revenue":null,"mechanism":""}],"pipeline":[{"drug_id":"odalasvir-75-mg","indication_name":"Chronic hepatitis C (treatment-naïve and treatment-experienced)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Odalasvir 75 mg","company_name":"Janssen Research & Development, LLC","drug_phase":"discontinued","molecular_target":"Hepatitis C virus NS5A protein","drug_class":"Direct-acting antiviral (DAA); NS5A inhibitor","quality_score":null,"revenue":null,"mechanism":"Odalasvir inhibits hepatitis C virus NS5A protein to block viral replication and assembly."}],"offLabel":[],"totalMarketed":2,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"OMNI Medical Services, LLC","has_results":false},{"nct_id":"NCT06248580","title":"Find HDV and Determine Its Status in Turkey","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Yaşar Bayındır, MD","has_results":false},{"nct_id":"NCT05181956","title":"Testing and Epidemiology of Delta Hepatitis","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Asian Pacific Liver Center at Coalition of Inclusive Medicine","has_results":false},{"nct_id":"NCT05062967","title":"Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":3257,"lead_sponsor_name":"Maimónides Biomedical Research Institute of Córdoba","has_results":false},{"nct_id":"NCT07274345","title":"Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Amira Mohamed Zidan","has_results":false},{"nct_id":"NCT07476703","title":"Expanded Studies on the SCAPIS Stockholm Reexamination Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Danderyd Hospital","has_results":false},{"nct_id":"NCT05766449","title":"Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT03993925","title":"Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT04690972","title":"\"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases\".","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT06072287","title":"The Living With a Long-Term Condition Study","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT05792878","title":"Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Beijing Ditan Hospital","has_results":false},{"nct_id":"NCT05723068","title":"Burden of Hepatitis D Virus (HDV) Infection in Italy","phase":"","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"University of Turin, Italy","has_results":false},{"nct_id":"NCT04135235","title":"Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B","phase":"","overall_status":"UNKNOWN","enrollment_count":440,"lead_sponsor_name":"Beijing Ditan Hospital","has_results":false},{"nct_id":"NCT01939197","title":"A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05203055","title":"Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Fuzhou General Hospital","has_results":false},{"nct_id":"NCT02789800","title":"Patient-Centred Innovations for Persons With Multimorbidity - Quebec","phase":"NA","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT03425994","title":"Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection","phase":"","overall_status":"UNKNOWN","enrollment_count":275,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT04850950","title":"Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"The First Affiliated Hospital of Zhengzhou University","has_results":false},{"nct_id":"NCT03597633","title":"Tenofovir Combination or Mono-therapy for MDR CHB","phase":"","overall_status":"UNKNOWN","enrollment_count":236,"lead_sponsor_name":"Korea University","has_results":false},{"nct_id":"NCT05669677","title":"Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease","phase":"","overall_status":"COMPLETED","enrollment_count":233,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03459768","title":"Cohort Study on People Who Inject Drugs in Senegal","phase":"","overall_status":"UNKNOWN","enrollment_count":208,"lead_sponsor_name":"French National Agency for Research on AIDS and Viral Hepatitis","has_results":false},{"nct_id":"NCT06180590","title":"The Efficacy of Vosevi in Treating DAA-experienced Patients","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"The Third Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT04501224","title":"The Efficacy and Safety of TAF vs Other NAs in Patients With LVL","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05466071","title":"Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Xingfei Pan","has_results":false},{"nct_id":"NCT01079806","title":"A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT02742597","title":"Patient-Centred Innovations for Persons With Multimorbidity - Ontario","phase":"NA","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT03852433","title":"Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT07200908","title":"A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":172,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT07499544","title":"A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT02738138","title":"A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT07417553","title":"A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Beijing Continent Pharmaceutical Co, Ltd.","has_results":false},{"nct_id":"NCT03852719","title":"Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT02642432","title":"A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05895448","title":"Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":125,"lead_sponsor_name":"Center For Hepatitis C, Atlanta, GA","has_results":false},{"nct_id":"NCT05786859","title":"The Efficacy and Safety of Rifaximin Treatment","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":124,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05771402","title":"A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"The Second Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT07307586","title":"A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Zhigang Ren","has_results":false},{"nct_id":"NCT05769816","title":"A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"The Second Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT07454837","title":"Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03546621","title":"A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Hepatera Ltd.","has_results":true},{"nct_id":"NCT06616103","title":"Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":111,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05147090","title":"Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":106,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT01639066","title":"Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT05861674","title":"A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT05956379","title":"Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03490097","title":"Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05523648","title":"Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Sichuan Leshan Traditional Chinese Medicine Hospital","has_results":false},{"nct_id":"NCT01639092","title":"Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT02207088","title":"Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT07295873","title":"Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":64,"lead_sponsor_name":"Beijing Continent Pharmaceutical Co, Ltd.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}